Combined use of bulbar conjunctival pedicle flap and labial mucous membrane graft for porous orbital implant exposure: Long-term outcome

References

• Patel PJ, Rees HC, Olver JM. Clinicopathologic reports, case reports, and small case series: fibrovascularization of porous polyethylene orbital floor implants in humans. Arch Ophthalmol. 2003;121(3):400–403.
   PubMedGoogle Scholar
• Kashkouli MB, Beigi B. Late reexposure after upper eyelid tarsoconjunctival flap for exposed porous orbital implant. Ophthalmic Surg Lasers Imaging. 2004;35(6):499–502.
   PubMedGoogle Scholar
• Martin P, Ghabrial R. Repair of exposed hydroxyapatite orbital implant by a tarsoconjunctival pedicle flap. Ophthalmology. 1998;105(9):1694–1697. doi:10.1016/S0161-6420(98)99040-6.
   PubMed Web of Science ®Google Scholar
• Soparkar CN, Patrinely JR. Tarsal patch-flap for orbital implant exposure. Ophthal Plast Reconstr Surg. 1998;14(6):391–397. doi:10.1097/00002341-199811000-00002.
   PubMed Web of Science ®Google Scholar
• Lu L, Shi W, Luo M, Sun Y, Fan X. Repair of exposed hydroxyapatite orbital implants by subconjunctival tissue flaps. J Craniofac Surg. 2011;22(4):1452–1456. doi:10.1097/SCS.0b013e31821d1860.
   PubMed Web of Science ®Google Scholar
• Tawfik HA, Budin H, Dutton JJ. Repair of exposed porous polyethylene implants utilizing flaps from the implant capsule. Ophthalmology. 2005;112(3):516–523. doi:10.1016/j.ophtha.2004.09.030.
   PubMed Web of Science ®Google Scholar
• Lee MJ, Khwarg SI, Choung HK, Kim NJ, Yu YS. Dermis-fat graft for treatment of exposed porous polyethylene implants in pediatric postenucleation retinoblastoma patients. Am J Ophthalmol. 2011;152(2):244–250 e242. doi:10.1016/j.ajo.2011.01.048.
   PubMed Web of Science ®Google Scholar
• Yoon KC, Yang Y, Jeong IY, Kook MS. Buccal mucosal graft for hydroxyapatite orbital implant exposure. Jpn J Ophthalmol. 2011;55(3):318–320. doi:10.1007/s10384-011-0005-7.
   PubMed Web of Science ®Google Scholar
• Sagoo MS, Olver JM. Autogenous temporalis fascia patch graft for porous polyethylene (Medpor) sphere orbital implant exposure. Br J Ophthalmol. 2004;88(7):942–946. doi:10.1136/bjo.2003.026823.
   PubMed Web of Science ®Google Scholar
• Massry GG, Holds JB. Frontal periosteum as an exposed orbital implant cover. Ophthal Plast Reconstr Surg. 1999;15(2):79–82. doi:10.1097/00002341-199903000-00003.
   PubMed Web of Science ®Google Scholar
• Ibanez-Flores N, Abia-Serrano M, Aznar-Pena I, et al. Pericranium grafts for exposed orbital implants: an observational case-series study. J Craniomaxillofac Surg. 2015;43(7):1017–1020. doi:10.1016/j.jcms.2015.06.008.
   PubMed Web of Science ®Google Scholar
• Liao SL, Kao SC, Tseng JH, Lin LL. Surgical coverage of exposed hydroxyapatite implant with retroauricular myoperiosteal graft. Br J Ophthalmol. 2005;89(1):92–95. doi:10.1136/bjo.2003.038778.
   PubMed Web of Science ®Google Scholar
• Kim JH, Khwarg SI, Choung HK, Yu YS. Management of porous polyethylene implant exposure in patients with retinoblastoma following enucleation. Ophthalmic Surg Lasers Imaging. 2004;35(6):446–452.
   PubMedGoogle Scholar
• Chen YH, Cui HG. Amniotic membrane transplantation for porous sphere orbital implant exposure. J Zhejiang Univ Sci B. 2007;8(9):616–619. doi:10.1631/jzus.2007.B0616.
   PubMedGoogle Scholar
• Kaynak P, Karabulut GO, Ozturker C, et al. Remove, rotate, and reimplant: a novel technique for the management of exposed porous anophthalmic implants in eviscerated patients. Eye (Lond). 2014;28(5):546–552. doi:10.1038/eye.2014.2.
   PubMed Web of Science ®Google Scholar
• Lee BJ, Lewis CD, Perry JD. Exposed porous orbital implants treated with simultaneous secondary implant and dermis fat graft. Ophthal Plast Reconstr Surg. 2010;26(4):273–276. doi:10.1097/IOP.0b013e3181bf24db.
   PubMed Web of Science ®Google Scholar
• Salour H, Owji N, Farahi A. Two-stage procedure for management of large exposure defects of hydroxyapatite orbital implant. Eur J Ophthalmol. 2003;13(9–10):789–793.
   PubMed Web of Science ®Google Scholar
• Shields CL, Shields JA, De Potter P, Singh AD. Problems with the hydroxyapatite orbital implant: experience with 250 consecutive cases. Br J Ophthalmol. 1994;78(9):702–706. doi:10.1136/bjo.78.9.702.
   PubMed Web of Science ®Google Scholar
• Kim YD, Goldberg RA, Shorr N, Steinsapir KD. Management of exposed hydroxyapatite orbital implants. Ophthalmology. 1994;101(10):1709–1715. doi:10.1016/S0161-6420(94)31112-2.
   PubMed Web of Science ®Google Scholar
• Karsloglu S, Serin D, Simsek I, Ziylan S. Implant infection in porous orbital implants. Ophthal Plast Reconstr Surg. 2006;22(6):461–466. doi:10.1097/01.iop.0000248156.41020.94.
   PubMed Web of Science ®Google Scholar
• Levine MR. Extruding orbital implant: prevention and treatment. Ann Ophthalmol. 1980;12(12):1384–1386.
   PubMedGoogle Scholar
• Buettner H, Bartley GB. Tissue breakdown and exposure associated with orbital hydroxyapatite implants. Am J Ophthalmol. 1992;113(6):669–673. doi:10.1016/S0002-9394(14)74792-0.
   PubMed Web of Science ®Google Scholar
• Custer PL, Trinkaus KM. Porous implant exposure: incidence, management, and morbidity. Ophthal Plast Reconstr Surg. 2007;23(1):1–7. doi:10.1097/01.iop.0000249432.18688.ee.
   PubMed Web of Science ®Google Scholar
• Weinberg DA, Tham V, Hardin N, et al. Eyelid mucous membrane grafts: a histologic study of hard palate, nasal turbinate, and buccal mucosal grafts. Ophthal Plast Reconstr Surg. 2007;23(3):211–216. doi:10.1097/IOP.0b013e318050d2d1.
   PubMed Web of Science ®Google Scholar
• Fishman JA, Greenwald MA, Grossi PA. Transmission of infection with human allografts: essential considerations in donor screening. Clin Infect Dis. 2012;55(5):720–727. doi:10.1093/cid/cis519.
   PubMed Web of Science ®Google Scholar
• Mehta JS, Franks WA. The sclera, the prion, and the ophthalmologist. Br J Ophthalmol. 2002;86(5):587–592. doi:10.1136/bjo.86.5.587.
   PubMed Web of Science ®Google Scholar
• Schmitz JP, Hollinger JO, Milam SB. Reconstruction of bone using calcium phosphate bone cements: a critical review. J Oral Maxillofac Surg. 1999;57(9):1122–1126. doi:10.1016/S0278-2391(99)90338-5.
   PubMed Web of Science ®Google Scholar
• Yeatts RP, Grim W, Stanton C, Curry C. Injectable hydroxyapatite paste as an option for ocular implantation after evisceration. Ophthalmology. 2002;109(11):2123–2128. doi:10.1016/S0161-6420(02)01222-8.
   PubMed Web of Science ®Google Scholar
• Jordan DR. Problems after evisceration surgery with porous orbital implants: experience with 86 patients. Ophthal Plast Reconstr Surg. 2004;20(5):374–380. doi:10.1097/01.IOP.0000134273.06823.56.
   PubMed Web of Science ®Google Scholar
• Lee SY, Jang JW, Lew H, Kim SJ, Kim HY. Complications in motility PEG placement for hydroxyapatite orbital implant in anophthalmic socket. Jpn J Ophthalmol. 2002;46(1):103–107. doi:10.1016/S0021-5155(01)00459-2.
   PubMed Web of Science ®Google Scholar
• Yoon JS, Lew H, Kim SJ, Lee SY. Exposure rate of hydroxyapatite orbital implants a 15-year experience of 802 cases. Ophthalmology. 2008;115(3):566–572 e562. doi:10.1016/j.ophtha.2007.06.014.
   PubMed Web of Science ®Google Scholar